Position in NERV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$146,600
+$102,160 QoQ
Shares Held
24,332
+120.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. NERV ranks #342 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in NERV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $146,600 | 24,332 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,440 | 11,055 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $23,171 | 11,008 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $18,933 | 11,008 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $18,705 | 11,004 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $35,782 | 16,104 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $28,694 | 10,747 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $34,282 | 10,747 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $27,726 | 10,747 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $38,658 | 6,286 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $93,874 | 13,605 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $82,213 | 8,995 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,719 | 8,575 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,793 | 8,675 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $125,702 | 13,619 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,143 | 6,992 | Shares | Defined | 2022-10-27 | |
| No filing history on record for this holder in this stock. | ||||||